The Key Extended Entry Program (KEEP): A methadone treatment program for opiate-dependent inmates

Vincent Tomasino, Arthur J. Swanson, James Nolan, Harry I. Shuman

Research output: Contribution to journalArticle

67 Scopus citations

Abstract

The Key Extended Entry Program (KEEP) is the only known methadone treatment program for incarcerated opiate-dependent inmates in the United States. Initiated in 1987. KEEP performs approximately 18,000 detoxifications and 4,000 admissions for methadone treatment per year. Of those methadone treatment patients discharged to the community, mostly to outpatient KEEP programs, 74-80% report to their designated program. Recidivism rates reveal that 79% of KEEP patients were incarcerated again only once or twice during a recent 11-year period. Finally. KEEP data point to the importance of dedicating slots in the community for released inmates and maintaining them on sufficient blocking doses to eliminate the craving for heroin. About 6% of KEEP patients, some with mental illness, have a high incidence of recidivism.

Original languageEnglish (US)
Pages (from-to)14-20
Number of pages7
JournalMount Sinai Journal of Medicine
Volume68
Issue number1
StatePublished - Jan 1 2001

Keywords

  • Correctional treatment
  • Discharge planning
  • Jail
  • Methadone
  • Recidivism

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'The Key Extended Entry Program (KEEP): A methadone treatment program for opiate-dependent inmates'. Together they form a unique fingerprint.

  • Cite this